Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mydecine Innovations Group Inc MYCOF


Primary Symbol: C.MYCO

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning... see more

CSE:MYCO - Post Discussion

Mydecine Innovations Group Inc > MYCO.C L2 CHART WEDGE
View:
Post by Charts1 on Feb 17, 2021 2:04pm

MYCO.C L2 CHART WEDGE

POSSIBLE BREAKOUT ON THIS PULL BACK

Orders Shares Bid Ask Shares Orders
15 148,500 0.54 0.55 23,000 9
20 469,500 0.53 0.56 49,500 4
32 238,000 0.52 0.57 33,000 4
26 221,000 0.51 0.58 24,500 6
40 238,500 0.50 0.59 53,500 5
Comment by 666999 on Feb 17, 2021 3:28pm
Agree, chart is bullish, it should move higher, same pattern, but for last 3 month is moving higher
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities